Brainstorm Cell Therapeutics Inc (NAS:BCLI)
$ 0.3281 -0.0125 (-3.71%) Market Cap: 26.16 Mil Enterprise Value: 24.35 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 31/100

Brainstorm Cell Therapeutics Inc (BCLI) Transcripts

  • 1